Circumcision - Large Biopsy 3-6 cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Large foreskin biopsy.

₹666₹951

30% OFF

Circumcision - Large Biopsy 3-6 cm: Complete Medical Information Guide

Section 1: Why is it done?
- Test Purpose: Histopathological examination of penile tissue obtained during circumcision procedure to detect malignancy, benign lesions, inflammatory conditions, and infectious diseases affecting the foreskin.
- Primary Indications: Detection of squamous cell carcinoma, basal cell carcinoma, or other malignancies of the foreskin
- Evaluation of suspicious lesions, nodules, or abnormal tissue appearance on the prepuce
- Assessment of chronic inflammatory conditions such as lichen sclerosus or balanitis xerotica obliterans
- Investigation of recurrent infections, erosions, or ulcerations unresponsive to standard treatment
- Confirmation of HPV-related changes or penile intraepithelial neoplasia (PeIN)
- Timing: Performed during or immediately after circumcision procedure; specimen submitted to pathology laboratory for analysis within 24 hours of surgical removal
Section 2: Normal Range
- Normal Findings: Benign mature stratified squamous epithelium without keratinization, normal dermal tissue with minimal chronic inflammation, intact basement membrane, and absence of dysplastic changes
- Expected Components: Normal foreskin tissue measuring 3-6 cm with epithelium, dermis, and subcutaneous tissue; normal vascular structures and nerve fibers; no malignant cells or significant pathology
- Negative/Normal Result Interpretation: "No malignancy identified" - indicates absence of cancerous cells, dysplasia, or significant pathological changes; reassuring for patient with suspicious clinical presentation
- Borderline/Minor Findings: Mild chronic inflammation, benign keratosis, mild acanthosis, minimal koilocytic changes without dysplasia - typically do not require additional intervention
Section 3: Interpretation
- Malignant Findings:
- Squamous Cell Carcinoma (SCC) - presence of invasive malignant cells with infiltration through basement membrane; varies in grade (well-differentiated, moderately-differentiated, poorly-differentiated); requires oncology consultation and possible further treatment including chemotherapy or radiation
- Basal Cell Carcinoma - nests of basaloid cells with peripheral palisading; generally has better prognosis than SCC
- Melanoma - presence of atypical melanocytes with increased mitotic activity; high risk lesion requiring aggressive treatment
- Premalignant/Dysplastic Findings:
- Penile Intraepithelial Neoplasia (PeIN) - abnormal epithelial cells confined to epidermis without invasion; classified as grade 1, 2, or 3 based on extent of dysplasia; risk of progression to invasive carcinoma; requires close follow-up and possible adjunctive treatment
- Lichen Sclerosus - atrophic epithelium with homogenization of superficial dermis, band-like inflammation; associated with increased malignancy risk if left untreated
- Inflammatory/Infectious Findings:
- Chronic balanoposthitis - lymphocytic infiltration, epithelial erosion, may include causative organism identification if present
- HPV-related changes - koilocytic atypia, acanthosis, parakeratosis; indicates active HPV infection requiring monitoring
- Factors Affecting Results:
- Specimen adequacy - must be properly sized (3-6 cm) and include full thickness tissue layers
- Fixation quality - immediate fixation in formalin prevents tissue artifact and autolysis
- Sectioning technique - multiple sections ensure representative sampling of tissue
- Staining methods - standard H&E staining plus specialized stains (immunohistochemistry, HPV detection) when indicated
Section 4: Associated Organs
- Primary Organ System: Integumentary system and male genitourinary system; specifically the prepuce (foreskin) - stratified squamous epithelium with specialized vascular and nerve supply
- Associated Diseases/Conditions:
- Penile Cancer - potentially metastatic to regional inguinal lymph nodes, iliac lymph nodes, and distant organs; mortality rate 25-50% in advanced cases
- HPV-related penile intraepithelial neoplasia - strongly associated with HPV-16 and HPV-18; linked to cervical and anal cancers in sexual partners
- Lichen Sclerosus - chronic inflammatory condition with phimosis risk; 10-15% malignant transformation rate over 10-20 years
- Balanitis Xerotica Obliterans - scarring condition potentially affecting urinary and sexual function; low malignancy risk but requires monitoring
- Potential Complications:
- Lymphatic spread to inguinal and pelvic nodes in malignant cases requiring surgical staging and possible node dissection
- Hematologic dissemination in advanced disease affecting liver, lungs, bone, and brain
- Sexual dysfunction and erectile complications if treatment involves partial penectomy or chemotherapy
- Urinary obstruction if scarring or malignancy involves urethral meatus
- Psychological impact from diagnosis of malignancy affecting quality of life and sexual function
Section 5: Follow-up Tests
- If Malignancy Detected:
- MRI pelvis - for staging penile cancer and assessing invasion depth; essential for surgical planning
- CT chest and abdomen - to rule out distant metastases in lung, liver, and abdominal organs
- Inguinal lymph node assessment - ultrasound, fine-needle aspiration, or sentinel node biopsy to determine nodal involvement
- PET-CT - for metabolically active disease assessment and detection of occult metastases
- Oncology consultation - for chemotherapy eligibility and treatment planning
- If Dysplasia/Premalignant Findings:
- HPV genotyping - if koilocytic changes present, to determine HPV strain (high-risk vs low-risk types)
- p16 immunohistochemistry staining - to confirm HPV-related changes and assess malignant potential
- Clinical photography and documentation - baseline images for monitoring progression
- Regular clinical examination - every 3-6 months for first 2 years, then annually to detect recurrence or progression
- If Lichen Sclerosus Confirmed:
- Topical corticosteroid therapy - fluticasone or clobetasol for symptom relief and disease management
- Annual or biannual clinical surveillance - given 10-15% risk of malignant transformation
- Repeat biopsy if new suspicious lesions develop or inadequate response to treatment
- If Inflammatory/Infectious Changes:
- Bacterial/fungal culture if infectious organism identified - to guide targeted antibiotic or antifungal therapy
- STI screening - if sexually transmitted infection suspected based on histology
- Partner notification and treatment - if communicable disease identified
- Clinical follow-up at 2-4 weeks post-circumcision - to assess healing and confirm resolution of inflammation
- Monitoring Frequency:
- Malignancy: Regular oncology follow-up every 1-3 months during first year; then every 3-6 months for 5 years minimum
- PeIN: Clinical assessment every 3-6 months indefinitely; repeat biopsy if changes observed
- Lichen Sclerosus: Annually or biannually for lifetime; more frequently if atypical features or symptoms develop
Section 6: Fasting Required?
- Fasting Required: NO - This is a surgical specimen biopsy, not a blood test
- Pre-operative Preparation:
- General anesthesia requirement - NPO (nothing by mouth) 6-8 hours before surgery as per anesthesia guidelines
- Clear liquids may be permitted 2-4 hours before procedure per surgeon's instructions
- Adequate hydration - drink water up to allowed NPO deadline to prevent dehydration
- Medications to Avoid:
- Aspirin and NSAIDs - discontinue 5-7 days before surgery to reduce bleeding risk
- Anticoagulants (warfarin, apixaban) - coordinate timing with surgeon; may require bridging therapy
- Herbal supplements - discontinue 1-2 weeks before surgery if patient using ginseng, ginkgo, St. John's Wort, or other anticoagulant herbs
- Certain medications may be taken with small sip of water on morning of surgery per protocol
- Additional Preparation Requirements:
- Personal hygiene - thorough cleansing of genital area morning of procedure; regular soap and water only
- Hair removal - genital area may be clipped (not shaved) 24 hours before surgery to reduce infection risk
- Bowel preparation - not typically required unless combined with other procedures
- Remove all jewelry, piercings, dentures, glasses, hearing aids before entering surgical suite
- Empty bladder immediately before surgery to reduce catheterization risk and improve operative field visualization
- Skin antisepsis - genital area will be prepped with chlorhexidine or povidone-iodine in operating room
- Specimen handling - tissue immediately fixed in 10% neutral buffered formalin to preserve cellular architecture and prevent autolysis

How our test process works!